t(9;11) (p21-22;q23); (MLL-AF9) PCR QUALITATIVE
202 Ratings
Rs 4,160 Rs 3,200
23 % OFF
CHROMOSOMAL REARRANGEMENTS CAN PRODUCE TUMORIGENIC FUSION GENES. THIS MECHANISM IS SEEN IN 15-25% OF LEUKEMIAS, LYMPHOMAS & SARCOMAS. FUSIONS CAN BE PRODUCED BY TRANSLOCATIONS, INVERSIONS OR DELETIONS. SPECIFIC GENE FUSIONS IN A PATIENTS TUMOR CELLS HAVE AN IMPORTANT BEARING ON THE MANAGEMENT & PROGNOSIS. THIS ASSAY DETECTS MLL-AF9 FUSION GENE WHICH IS THE MOST COMMON MLL ABNORMALITY IN AML.
Why book with us?
-
Free and On Schedule Sample Collection
-
24/7 Service
-
Affordable
-
Quick and Accurate Reports
3 ML (2 ML MIN.) WHOLE BLOOD / BONE MARROW IN 1 LAVENDER TOP (EDTA) TUBE. SHIP REFRIGERATED. DO NOT FREEZE. CLINICAL HISTORY IS MANDATORY.
REAL TIME PCR
REPORT ON 15TH DAY EVENING 7PM
CLINICAL HISTORY IS MANDATORY.
